Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis.
about
Immune mechanisms of protection: can adjuvants rise to the challenge?Does BCG have a role in tuberculosis control and prevention in the United Kingdom?Tuberculosis vaccines: beyond bacille Calmette-GuerinProtective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcerInvasion of the central nervous system by intracellular bacteriaSafety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South AfricaRecombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal modelControl and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic SocietyApplications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapyEpidemiology and disease burden of tuberculosis in children: a global perspectiveHost immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosisMicroglia are crucial regulators of neuro-immunity during central nervous system tuberculosisDiagnosis and management of miliary tuberculosis: current state and future perspectivesA nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungsSerum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85APreclinical evidence for implementing a prime-boost vaccine strategy for tuberculosisSafety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trialEstablishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testingA review of the literature on the economics of vaccination against TB.The benefits and risks of bacille Calmette-Guérin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model.Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trialsNatural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants.A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.Miliary tuberculosis in an immunocompetent male with a fatal outcome.Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85AImpact of bacille Calmette-Guérin vaccination on neuroradiological manifestations of pediatric tuberculous meningitis.Enhanced antimycobacterial response to recombinant Mycobacterium bovis BCG expressing latency-associated peptide.Paediatric tuberculosis.The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.A New Adjuvant MTOM Mediates Mycobacterium tuberculosis Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2+ T Cells.Role of bacille Calmette-Guérin in preventing tuberculous infectionTuberculosis: 10. PreventionSaudi guidelines for testing and treatment of latent tuberculosis infectionNon-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study.Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda.Tuberculosis in household contacts of infectious cases in Kampala, UgandabioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.BCG vaccination in South African HIV-exposed infants--risks and benefitsDual neonate vaccine platform against HIV-1 and M. tuberculosis.
P2860
Q21245319-9C92C0C6-503D-4FF7-9F77-6B81A175B2CDQ22242220-453C2CD5-E1F8-441F-96E1-87B2CF298EF5Q22242669-52FE30FD-4C91-47DA-9A58-947E06687E61Q24548647-76805CA8-95A9-4695-AF48-11E0415E66C6Q24625439-48604833-473A-484F-B766-18C4AB21B348Q24647137-5594033C-272E-41A7-AF8D-641C4E8BF834Q24675231-CD6810FF-D884-4E7C-BB6C-AF92E8EC7260Q24679389-73F1BD83-206C-40C7-88A6-20FCE80CB850Q26798372-6EB129E8-E42E-47EA-A9BF-1629878037A5Q26849514-20E308D3-9A51-4C3F-AC0F-C2A78B858183Q26863391-B90B69B2-EA6A-4952-B05C-C6EAA34329E5Q28082627-162BD0B0-E45D-4C80-AB53-DFB56DD6A77AQ28393022-10BBA3F7-B28E-4D77-A0B4-2D71B06D464FQ28396228-AE224FDB-CA9B-4381-85F1-C8AA3A0A55D0Q28649845-F61E0930-37E8-4987-98BD-D44560EEDEB4Q28730427-2CE16AFF-7684-4AF0-A400-1B469BC90E25Q29620144-BB46AA18-6941-4509-8C8D-310B772518C9Q30227121-507C0E02-D63B-4C80-812D-4F8F2AAA3D2DQ30413692-4E4BF1B7-3CA2-45C9-9C1A-9935AC0FBB00Q33235419-77456D5E-AAB1-47EF-BA3B-AA345A9E41CDQ33303660-19F36D01-1F80-4443-AAB6-DF1492504842Q33378483-7CF24ABE-3E96-4D48-9979-6BBAB2E91B61Q33432697-636AC9A6-3B4B-47B0-8910-EB8139212373Q33436498-B70B19DE-57A4-4C68-8DE9-D20DB64C4511Q33468451-B7DA7503-C109-4BA0-BE07-E632EB9A1D82Q33507764-E1B50D2B-B3C4-42B1-B4BD-D3854A4E3841Q33552182-7DED2296-BACC-4702-944C-2C1E3C8D9108Q33581724-31D8961B-6C2E-4B43-863A-C8857907FD7EQ33637297-750861EF-33D5-4FD2-9280-8986526DF7F1Q33703027-4817D821-BA42-43C0-9792-93AF903B3249Q33746120-5782F029-E4BC-4861-9407-E633D305FF36Q33747666-07FC4902-9AC4-427E-8993-317D88A06F4AQ33772114-E40D13EC-20D4-4049-9EAE-ADA69A9958BEQ33791961-1B3E98B0-A488-4DCA-81AB-49E98E11DF45Q33804506-1DADFB4A-DD3E-41A2-9328-A151446949B2Q33847573-F14624C0-58FE-4C60-8C20-7191CF92DD1EQ33847585-9EB4D791-DFA1-44F9-8100-298F525137DCQ33848397-2FFFA8B6-7FAB-42DD-A541-6F68D1BB8B42Q33848471-0D223FEC-56DD-481F-AC0E-AD5BF3BAA525Q33908584-EF462D8F-534B-4998-B5A8-BE01878AB517
P2860
Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis.
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Protective effect of BCG again ...... tuberculosis: a meta-analysis.
@ast
Protective effect of BCG again ...... tuberculosis: a meta-analysis.
@en
Protective effect of BCG again ...... tuberculosis: a meta-analysis.
@nl
type
label
Protective effect of BCG again ...... tuberculosis: a meta-analysis.
@ast
Protective effect of BCG again ...... tuberculosis: a meta-analysis.
@en
Protective effect of BCG again ...... tuberculosis: a meta-analysis.
@nl
prefLabel
Protective effect of BCG again ...... tuberculosis: a meta-analysis.
@ast
Protective effect of BCG again ...... tuberculosis: a meta-analysis.
@en
Protective effect of BCG again ...... tuberculosis: a meta-analysis.
@nl
P2093
P921
P356
P1476
Protective effect of BCG again ...... tuberculosis: a meta-analysis.
@en
P2093
Rodrigues LC
Wheeler JG
P304
P356
10.1093/IJE/22.6.1154
P577
1993-12-01T00:00:00Z